جست‌وجوی استاد و پژوهشگر

Youngjae Youمشاهده پروفایل

استاد

• Antibody-Drug Conjugates
• Cancer Chemotherapy
• Medicinal Chemistry
• +۳ مورد دیگر

Youngjae You is a Professor of Empire Innovation in the Department of Pharmaceutical Sciences at the University at Buffalo School of Pharmacy. His research focuses on Antibody-Drug Conjugates, Cancer Chemotherapy, Medicinal Chemistry, and Targeted Drug Delivery. He holds adjunct roles at the University of Oklahoma Health Sciences Center and has led numerous grants totaling over $10 million in funding. Key awards include the 2019 Professor of Empire Innovation title and multiple DoD/CDMRP grants. His work emphasizes prodrug design, photodynamic therapy, and combination therapies. Education : PhD in Pharmaceutical Chemistry, Chungnam National University (2001) MS in Pharmaceutical Chemistry, Chungnam National University (2000) BPharm, Chungnam National University (1994) Research Interests : Dr. You specializes in developing light-activatable prodrugs for targeted cancer therapies, including far-red/NIR light-activated delivery systems. His work integrates quantitative pharmacokinetic modeling, singlet oxygen dynamics, and receptor-targeted drug conjugation to enhance therapeutic efficacy while minimizing off-target effects. Key applications include bladder, breast, and ovarian cancers. Funding Highlights : NIH/NIGMS: $1.37M (2023-2027) for light-responsive drug delivery National Cancer Institute: $2.1M (2022-2027) for bladder cancer treatments DoD/CDMRP/PRCRP: $392K (2017-2020) for photodynamic-chemotherapy combinations Awards : PHF Presidential Professorship (2018) American Cancer Society Research Scholar Grant (2013) Multiple DoD/CDMRP Idea Awards Service & Grants : Serves as Principal Investigator on 8 major grants. Active reviewer for Wellcome Trust, NIH, and international funding agencies. Holds patents on BODIPY derivatives and singlet oxygen-labile linkers. Lab & Collaborations : Leads the You Lab at UB, collaborating with bioengineers and clinicians to advance photomedicine and targeted drug delivery systems. Engaged in multidisciplinary teams addressing spatiotemporal control in cancer treatments.

Wengong Jinمشاهده پروفایل

استادیار

• AI for drug discovery
• Generative AI models
• Geometric deep learning
• +۵ مورد دیگر

Wengong Jin is an Assistant Professor at the Khoury College of Computer Sciences, Northeastern University, and a visiting research scientist at the Eric and Wendy Schmidt Center at the Broad Institute. He holds a PhD from MIT CSAIL, advised by Prof. Regina Barzilay and Prof. Tommi Jaakkola. Research Interests: His work focuses on geometric and generative AI models for drug discovery, biology, and chemical engineering. Key areas include equivariant neural networks (e.g., FAFormer), diffusion models for binding energy prediction, antibody/enzyme design (RefineGNN, SurfPro), and molecular design through graph neural networks (Junction Tree VAE). He also explores domain generalization and systems for autonomous molecular discovery. Publications: His research has been published in top venues like NeurIPS, ICLR, ICML, Nature, Science, and Cell. Recent breakthroughs include discovering novel antibiotics using explainable AI and designing synergistic drug combinations for cancer treatment. Awards: He has received the BroadIgnite Award, Dimitris N. Chorafas Prize, and MIT EECS Outstanding Thesis Award for his contributions to computational biology and AI-driven drug discovery. Teaching: Currently teaches a PhD seminar on AI for Science, focusing on integrating machine learning into scientific discovery processes.

Jennifer Whittyمشاهده پروفایل

استاد

• Health Economics
• Preferences for Health and Health Care
• Valuing Health Outcomes
• +۷ مورد دیگر

Professor Jennifer Whitty is an applied health economist at the University of East Anglia , affiliated with the Norwich Medical School and the Centre of Research Excellence in Telehealth . Her research bridges health economics, patient preferences, and health policy, with a focus on quality of life valuation and economic evaluation. Education: Doctor of Philosophy (Griffith University, 2008), Graduate Diploma in Clinical Pharmacy (University of Queensland, 2002), Bachelor of Pharmacy (University of Wales, 1992) Her work emphasizes person-centered methodologies , particularly discrete choice experiments, to evaluate patient and public preferences for healthcare delivery and outcomes. Key research areas include: Treatment burden and quality of life in chronic diseases like cystic fibrosis Economic evaluation of pharmaceuticals and health technologies Asset-based approaches to community health Priority-setting frameworks in health policy Prof. Whitty has secured over AU$27 million in research funding from organizations including the NHMRC and National Institute for Health and Care Research , and serves on editorial boards for Medical Decision Making and Applied Health Economics and Health Policy .

Cristian Gómez Canelaمشاهده پروفایل

استاد

• Environmental Chemistry
• Analytical Chemistry
• Mass Spectrometry
• +۵ مورد دیگر

Cristian Gómez Canela is a Full Professor in the Department of Analytical and Applied Chemistry at the School of Engineering, Ramon Llull University (IQS). He serves as Coordinator of the Master's Degree in Analytical Chemistry and is an active member of the Catalan Chemical Society (SCQ), representing SCQ in EuChems-EYCN. His academic journey includes a PhD in Chemistry from the University of Barcelona (2014), followed by postdoctoral research at IDAEA-CSIC and King's College University. Dr. Gómez Canela's research focuses on environmental analytical chemistry, particularly the optimization and validation of analytical methods based on liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) and high-resolution mass spectrometry (HRMS) for determining organic pollutants in environmental samples. His work extends to metabolomics applied to aquatic organisms and the analysis of neurotoxic compounds in water systems. His research fingerprint reveals strong expertise in zebrafish models (100%), neurotransmitter analysis (66%), Daphnia magna studies (64%), and neurotoxicity assessment (21%). His recent publications (2024-2025) demonstrate a clear trend toward environmental neurotoxicology, with emphasis on the effects of pharmaceuticals and industrial pollutants on aquatic organisms. His work integrates advanced analytical techniques with biological endpoints to assess environmental risks, particularly focusing on neurological and cardiovascular impacts. The research spans method development for pollutant detection, environmental monitoring, and mechanistic studies of neurotoxic effects. Dr. Gómez Canela leads multiple significant research projects including CHEMIPARK (2024-2027) on passive sampling methodologies for environmental pollutants, GESPA (2022-2025) as part of the Environmental Process Engineering and Simulation Group, and several projects on neuroactive compounds in water systems. He has an impressive research output with 91 scientific publications from 2011-2025 and an h-index of 27 with over 2,000 citations. As a dedicated educator, he contributes to multiple academic programs including the Master in Analytical Chemistry, Master in Pharmaceutical Chemistry, and undergraduate degrees in Chemistry and Chemical Engineering. His research group GESPA represents a multidisciplinary team combining chemical engineering, biotechnology, and chemical analysis to advance environmental sustainability through theoretical and experimental approaches.

• Additive Manufacturing
• Aerospace Engineering
• Thermofluids
• +۱ مورد دیگر

Associate Professor Ng Bing Feng leads research in Additive Manufacturing, Aerospace Engineering, and Thermofluids at Nanyang Technological University's School of Mechanical & Aerospace Engineering. As Cluster Director for Smart & Sustainable Building Technologies at NTU's Energy Research Institute, he oversees projects spanning energy-efficient cooling technologies, advanced filtration systems, and bio-inspired materials. His interdisciplinary work integrates advanced manufacturing with environmental engineering, focusing on sustainable solutions for air quality management and thermal regulation. Current research explores radiative cooling technologies, acoustic agglomeration for emissions control, and crashworthy structures via biomimetic design. Professor Ng's publications demonstrate consistent innovation in multi-scale manufacturing and fluid dynamics, with growing emphasis on sustainable urban technologies. Methodologies combine experimental fluid dynamics with computational modeling and AI-driven design. Leadership Roles: Cluster Director, Energy Research Institute @ NTU Principal Investigator for multiple industry collaborations in sustainable materials Research Output: 42+ publications in high-impact journals Multiple patents in filtration technologies and cooling systems

Ahmet Acarمشاهده پروفایل

دانشیار

• Cancer Biology
• Precision Medicine
• Drug Resistance Mechanisms
• +۳ مورد دیگر

Dr. Ahmet Acar is an Associate Professor at the Department of Biological Sciences, Middle East Technical University (METU), Ankara, Turkey. He leads the Cancer Precision Medicine and Drug Resistance Laboratory, focusing on understanding mechanisms of drug resistance in cancer. His research integrates experimental models, next-generation sequencing, and deep learning to address clinical challenges in cancer therapy. Dr. Acar holds a B.Sc. from METU's Biological Sciences department and a Ph.D. from the Cancer Research UK Manchester Institute. He completed postdoctoral training at the Institute of Cancer Research, London, and the University of Manchester. Research Interests: Drug resistance mechanisms, precision oncology, tumor microenvironment modeling, patient-derived organoids, computational pathology, and evolutionary cancer biology. His lab develops 2D/3D co-culture systems, PDO biobanks, and AI-driven histopathology tools to improve treatment strategies. Recent Work Trends: Recent publications emphasize tumor evolution modeling, matrix mechanics in drug resistance, and AI applications in histopathology. Collaborations with hospitals in Turkey and Europe support PDO biobank initiatives. His team explores evolutionary steering strategies to exploit collateral drug sensitivities. Labs/Teams: Precision Medicine and Drug Resistance Lab at METU focuses on interdisciplinary approaches combining wet-lab experiments with computational methods. Current projects include ex vivo tumor modeling and AI-driven diagnostic tools for oncology.

Takako Fujiokaمشاهده پروفایل

دانشیار

• Auditory Perception
• Neural Oscillations
• Auditory-Motor Coupling
• +۵ مورد دیگر

Takako Fujioka is an Associate Professor of Music at Stanford University, affiliated with the Center for Computer Research in Music and Acoustics (CCRMA). Her research focuses on the neural mechanisms underlying auditory perception, auditory-motor coupling, and music-supported therapy for neurorehabilitation. She holds a Ph.D. in Physiology from the Graduate University for Advanced Studies, Japan, and M.Sc./B.Eng. degrees in Electrical Engineering from Waseda University. Her work combines neurophysiological techniques such as MEG and EEG to study brain plasticity in development, aging, and stroke recovery. Notable contributions include investigating how music influences motor and cognitive recovery in stroke patients, as well as exploring the neural basis of musical perception through rhythmic synchronization and pitch discrimination studies. Supported by awards from the Canadian Institutes of Health Research during her postdoctoral work at the Rotman Research Institute, her research bridges clinical neuroscience and music cognition. Dr. Fujioka’s expertise spans auditory neuroscience, neurorehabilitation, and technology-assisted music therapy. She has pioneered studies on tactile mapping for cochlear implant users and networked music performance systems, emphasizing cross-modal perception and human-technology interaction. Her findings contribute to both theoretical understanding of auditory processing and practical applications in medical and educational settings. Awards: Canadian Institutes of Health Research Awards (postdoctoral phase) Labs/Teams: CCRMA, Stanford Music Perception Laboratory, Rotman Research Institute collaborations Key Themes: Neuroplasticity, Music-Mediated Rehabilitation, Auditory-Motor Integration, Multisensory Processing Her recent work examines aging-related changes in binaural hearing and the role of beta/gamma oscillations in rhythmic processing. She advocates for translational research that connects neural mechanisms with real-world therapeutic interventions.

Aaron Loganمشاهده پروفایل

دانشیار بالینی

• Hematology
• Oncology
• Immunology
• +۳ مورد دیگر

Dr. Aaron Logan is a Clinical Associate Professor of Medicine at the University of California, San Francisco (UCSF). He specializes in the clinical management of acute leukemias, myelodysplastic syndromes, aplastic anemia, and hemophagocytic lymphohistiocytosis. Additionally, he directs a research laboratory focused on immune repertoire profiling following hematopoietic cell transplantation. MD and PhD in Molecular Microbiology and Immunology from Keck School of Medicine (2006) MPhil in History of Medicine from University of Cambridge (2005) Internal Medicine Residency and Hematology Fellowship at Stanford University Dr. Logan's research explores clonotypic diversity in B and T lymphocyte repertoires, utilizing techniques like TREC/KREC quantification, high-throughput sequencing, and mixed lymphocyte reactions. His work has significant applications in tracking immune responses post-transplantation and quantifying measurable residual disease in lymphoid cancers. Notable scientific contributions include advancements in CAR T-cell therapy and immune profiling for blood malignancies. His publications cover topics in B-cell ALL , AML , and measurable residual disease monitoring. 2020 - UCSF Hematology-Oncology Fellowship Teaching Award 2011 - ASH Abstract Award and Research Training Award 2003 - Keck School of Medicine Outstanding Teaching Award As director of the UCSF Hematologic Malignancies Tissue Bank, Dr. Logan provides deidentified patient samples to support collaborative research on blood cancers and post-transplantation immune dynamics.

• Nuclear Magnetic Resonance (NMR)
• In vivo imaging
• MRI pulse sequence development
• +۷ مورد دیگر

Professor Guy Williams is a leading academic at the University of Cambridge with a focus on imaging science and clinical neurosciences, affiliated with Downing College and the Wolfson Brain Imaging Centre . Holding a PhD in Physics from his initial Natural Sciences degree, he specializes in nuclear magnetic resonance (NMR) and MRI techniques for brain imaging. Education: BA, PhD in Physics His research centers on non-invasive imaging of brain structure and function, particularly in traumatic brain injury (TBI) and dementia. His work involves developing novel MRI pulse sequences and advanced data analysis algorithms, including AI-based diagnostic tools. He leads studies on white matter integrity post-trauma, longitudinal dementia assessment, and applications of MRI in disorders of consciousness and addiction. Recent publications highlight collaborations in traumatic brain injury outcomes, AI-guided dementia prediction, and neuroimaging of post-COVID cognitive deficits. His team's work on ultra-high field laminar fMRI and distortion correction methods has advanced clinical neuroscience applications. Key techniques include diffusion tensor imaging (DTI), 7 Tesla MRI, and positron emission tomography (PET/MR). His research spans from basic NMR physics to clinical translation, with a strong emphasis on multi-site studies and real-world diagnostic implementation.

Karl Griswoldمشاهده پروفایل

استاد

• Protein engineering
• Directed evolution
• Biotherapeutics
• +۲ مورد دیگر

Karl Griswold is a Professor of Engineering at Dartmouth College's Thayer School of Engineering, where he leads the Griswold Research Group focused on protein engineering and biotherapeutics development. His interdisciplinary work spans chemical, biological, and engineering disciplines to address critical challenges in drug-resistant infections and protein therapeutics. Education: BS in Chemistry from Southwest Texas State University (1995) PhD in Chemistry from the University of Texas at Austin (2005) Research Focus: Professor Griswold's laboratory specializes in protein engineering, directed evolution, and biotherapeutics development , creating novel biomolecules with superior functionality compared to natural proteins. The group develops high-throughput screening methods, protein deimmunization strategies, enhanced expression systems, and antibacterial agents targeting drug-resistant infections. Their work has significant translational potential for treating conditions like MRSA and Pseudomonas aeruginosa infections. Scientific Recognition: Wallace H. Coulter Foundation Early Career Translational Research Award in Biomedical Engineering (2008) NIH Biotechnology Training Grant (2000-2003) Royston M. Roberts - Regents Fellowship, University of Texas (1999) DOW Chemical Foundation Scholar, Texas State University (1991-1995) Senior Fellow, National Academy of Inventors Research Leadership: As co-founder and CEO of Stealth Biologics, Professor Griswold translates academic research into commercial applications. His work has secured NIH funding and Dartmouth Innovations Accelerator support, with research featured in Chemical & Engineering News, Vermont Public Radio, and the New Hampshire Union Leader for developing alternatives to traditional antibiotics. Research Environment: The Griswold Research Group maintains extensive collaborations across disciplines including clinical medicine, immunology, structural biology, and chemical engineering. This interdisciplinary approach prepares trainees for careers at the intersection of multiple scientific fields, with research focusing on Biomolecular Antimicrobial Therapies, Deimmunizing Protein Therapeutics, and Gene Library Construction Technologies.

• Virtual Reality
• Human-Computer Interaction
• Augmented Reality
• +۴ مورد دیگر

Marc Erich Latoschik is a Professor in the Department of Human-Computer Interaction at the University of Würzburg, Germany. He previously held roles at Bayreuth University, Bielefeld University, and FHTW Berlin. His research focuses on virtual and augmented reality, embodiment, human-computer interaction, and applications in health, education, and social systems. Education: Completed his PhD in 2001 at Bielefeld University with a thesis on multimodal interaction in virtual reality. Research Interests: Embodied interaction, virtual embodiment, presence and plausibility in VR/AR, avatar design, social virtual reality, health applications (e.g., VR therapy for body image issues), and XR security/privacy. Active in developing frameworks like Reality Stack I/O and MAIL for VR/AR research. Key Projects: ViTraS study on body image exercises in VR, avatars for mass use via smartphone reconstruction, and motion-based biometrics in XR. Collaborates with medical teams on cybersickness detection and emergency training simulations. Labs/Teams: Leads research groups on immersive technologies and social VR applications. Involved in interdisciplinary projects combining HCI, AI, and healthcare.

John A. Copland, IIIمشاهده پروفایل

استاد

• Cancer Biology
• Molecular Carcinogenesis
• Translational Research
• +۳ مورد دیگر

Dr. John A. Copland III is a Professor of Cancer Biology and Biochemistry & Molecular Biology at Mayo Clinic in Jacksonville, Florida. He leads the Cancer Biology and Translational Research Laboratory, focusing on molecular mechanisms of carcinogenesis, tumor progression, and development of targeted cancer therapies. Education: PhD in Physiology & Endocrinology (Medical College of Georgia), MS in Endocrinology (Medical College of Georgia), BS in Chemistry (Columbus College), with postdoctoral training at University of Texas Medical Branch. Research interests center on: Identifying tumor suppressor genes (e.g., RhoB, TBR3, GATA3) and oncogenes (e.g., FOXO3a, SCD1, NPTX2). Developing patient-derived xenografts and live cell models for personalized medicine. Designing SCD1 inhibitors via in silico modeling for clinical trials. Recent publications highlight his work on SCD1 inhibition in leukemia and thyroid cancer ImmunoPET imaging of thyroid tumors CRISPR-identified drug synergies in cholangiocarcinoma Patient-specific combination therapies using xenograft models

Nga Wun Liمشاهده پروفایل

مدرس ارشد

• Functional Garments
• Knitting Technology
• Smart Textiles
• +۳ مورد دیگر

Dr Nga Wun (Doris) Li is a Senior Lecturer at the University of Technology Sydney (UTS) within the Faculty of Design, Architecture and Building, Department of Fashion and Textiles. She leads research in seamless knitting technology, smart textiles, and sustainable fashion innovation. PhD in Fashion & Textile Design (HK PolyU, 2021) BA (Hons) in Fashion & Textiles (HK PolyU, 2012) Certifications in Wholegarment Machine (Shima Seiki, Japan) and Higher Education Pedagogy (UTS) Her research focuses on functional garments, knitting technology, and bio-informed textile design. Key projects include smart socks for DVT prevention , one-size sports bras , and buoyant swimwear for children . She combines knitting with machine learning and 3D printing for material innovation. Recent publications highlight her work on compression textiles (2025), wearable glucose sensors (2025), and knitted metasurfaces for acoustic comfort (2024). She has secured AU$52,000+ in grants across 5 funded projects. Fashion Design Award (Jeanswest, China) Outstanding Presentation & Research Paper Awards (2024) Dr Li supervises PhD and MPhil students in smart textiles and sustainable design while coordinating machine knitting courses. She collaborates with AiDLab (Hong Kong) and Powerhouse Museum (Australia).

Joshua Gessمشاهده پروفایل

دانشیار

• Thermal management
• Heat transfer
• Microelectronic cooling
• +۵ مورد دیگر

Joshua Gess is an Associate Professor in the Mechanical, Industrial, and Manufacturing Engineering department at Oregon State University's College of Engineering. He joined Oregon State in 2015 and serves as a co-principal investigator at the Enhanced Heat Transfer Laboratory, where he leads research in thermal management solutions for high-performance microelectronics. His educational background includes: PhD, Mechanical Engineering, Auburn University, 2015 MS, Mechanical Engineering, Auburn University, 2012 B.E., Mechanical Engineering, Vanderbilt University, 2005 Before academia, he worked as a mechanical engineer at SSOE Group (including consulting for Johns Manville) and Northrop Grumman where he focused on military communication equipment. Professor Gess specializes in advancing thermal management solutions for high-performance microelectronic equipment. His research spans multiple scales, examining single and two-phase heat transfer on the macro-scale with passive and active liquid immersion techniques, as well as on the micro and nano scale for complex embedded thermal management solutions. He combines fundamental heat transfer knowledge with novel experimental methods such as two-phase PIV and high-speed image capture to develop reliable and energy-efficient cooling solutions for demanding electronics systems. His publication record demonstrates a clear trajectory toward increasingly sophisticated thermal management solutions, with recent work focusing on additive manufacturing applications for cooling systems, semiconductor thermal management, and nuclear reactor cooling systems. His research has significant implications for data center energy efficiency, where even small improvements in cooling efficiency could save enormous amounts of energy that could be returned to the grid. Gess is deeply committed to mentoring graduate students, emphasizing the practical applications of engineering principles. He attributes his interest in engineering to childhood influences like the movie RoboCop and the TV series MacGyver, and finds the reality of engineering work just as gratifying as he'd imagined. He particularly values the moments when his graduate students "get it" and watching them grow with each new accomplishment. As a person with a disability himself, Gess is passionate about establishing more robust support systems for people with disabilities at Oregon State. He is working with the School of Public Health to start an adaptive sports program, with the goal of building infrastructure that allows anyone to feel welcome and pursue advanced degrees at the university.

Michael Baymمشاهده پروفایل

دانشیار

• Microbial Evolutionary Genomics
• Antibiotic Resistance
• Computational Biology
• +۷ مورد دیگر

Dr. Michael Baym is an Associate Professor of Biomedical Informatics at Harvard Medical School with affiliate appointments in Microbiology and the Laboratory of Systems Pharmacology, and as an Associate Member of the Broad Institute. He leads the Baym Lab, which studies microbial evolutionary genomics and antibiotic resistance through a hybrid of experimental, computational, and theoretical approaches. His research focuses on: Antibiotic Resistance Evolution and practical interventions Mobile Genetic Elements (plasmids, phages, transposons) Computational Genomic Algorithms for big data analysis Synthetic Biology tools and technologies Key recent publications explore phage discovery systems , phylogenetic compression of microbial genomes, and RNA-guided gene drives in plasmids. His work is supported by multiple NIH/NIGMS and NSF grants including a MIRA award. Scientific honors include: Packard Fellowship (2018) Pew Biomedical Scholarship (2020) Sloan Research Fellowship (2020) A. Clifford Barger Excellence in Mentoring Award (2021) SSQBio Mentorship Award (2022) The lab actively trains PhD students and postdoctoral fellows with alumni occupying academic and industry positions globally. Current team members include researchers from interdisciplinary backgrounds working at the intersection of experiment, computation, and theory .